Donesta Bioscience Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Donesta Bioscience General Information

Description

Developer of estrogen hormone for treatment of women's health issues. The company is the developer of Estetrol, a natural estrogen appearing to have few side effects than previous natural and synthetic estrogens, with applications for hormone replacement therapy and oral contraceptive products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • Boslaan 11
  • 3701 CH Zeist
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Donesta Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Donesta Bioscience‘s full profile, request access.

Request a free trial

Donesta Bioscience Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Donesta Bioscience‘s full profile, request access.

Request a free trial